US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Better Therapeutics Inc (BTTX)
Better Therapeutics Inc (BTTX) ニュース

BTTX

Better Therapeutics (BTTX)

Better Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BTTX

1 2 3 4 5 6 7 8 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/03/14	22 : 38	Business Wire	Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq	NASDAQ:BTTX	Better Therapeutics Inc
2024/03/11	22 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTTX	Better Therapeutics Inc
2024/03/05	23 : 25	Business Wire	Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers	NASDAQ:BTTX	Better Therapeutics Inc
2024/03/04	23 : 25	Business Wire	Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)	NASDAQ:BTTX	Better Therapeutics Inc
2024/03/04	22 : 51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTTX	Better Therapeutics Inc
2024/03/01	20 : 08	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:BTTX	Better Therapeutics Inc
2024/02/20	23 : 25	Business Wire	Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease	NASDAQ:BTTX	Better Therapeutics Inc
2024/02/13	06 : 28	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:BTTX	Better Therapeutics Inc
2024/02/06	23 : 43	Business Wire	Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment	NASDAQ:BTTX	Better Therapeutics Inc
2024/02/06	23 : 02	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:BTTX	Better Therapeutics Inc
2024/01/26	06 : 30	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:BTTX	Better Therapeutics Inc
2024/01/24	07 : 22	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:BTTX	Better Therapeutics Inc
2024/01/17	23 : 28	Business Wire	Better Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone	NASDAQ:BTTX	Better Therapeutics Inc
2024/01/10	21 : 01	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:BTTX	Better Therapeutics Inc
2024/01/09	06 : 42	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTTX	Better Therapeutics Inc
2024/01/05	04 : 00	Business Wire	Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States	NASDAQ:BTTX	Better Therapeutics Inc
2024/01/02	21 : 45	Business Wire	Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease	NASDAQ:BTTX	Better Therapeutics Inc
2023/12/29	11 : 23	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:BTTX	Better Therapeutics Inc
2023/12/28	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BTTX	Better Therapeutics Inc
2023/12/22	07 : 21	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:BTTX	Better Therapeutics Inc
2023/12/21	07 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BTTX	Better Therapeutics Inc
2023/12/21	07 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BTTX	Better Therapeutics Inc
2023/12/21	07 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BTTX	Better Therapeutics Inc
2023/12/14	07 : 24	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:BTTX	Better Therapeutics Inc
2023/12/14	07 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTTX	Better Therapeutics Inc
2023/12/08	10 : 09	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:BTTX	Better Therapeutics Inc
2023/12/01	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTTX	Better Therapeutics Inc
2023/11/28	21 : 45	Business Wire	Better Therapeutics Strengthens Financial Position Through Amendment to Debt Facility and Implementation of Cost Reductions	NASDAQ:BTTX	Better Therapeutics Inc
2023/11/21	07 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BTTX	Better Therapeutics Inc
2023/11/14	21 : 00	Business Wire	Frost & Sullivan Honors Better Therapeutics with the 2023 Technology Innovation Leadership Award	NASDAQ:BTTX	Better Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:BTTX

1 2 3 4 5 6 7 8 次へ >>

American Express

US Dollar vs Euro

Verizon Communications

US Dollar vs Sterling

JP Morgan Chase

Gold vs US Dollar

Bank of America

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約